RAMM Pharma Corp. (CSE:RAMM)

RAMM Pharma Revenue

RAMM Pharma had revenue of 212.72K CAD in the quarter ending January 31, 2026, a decrease of -78.94%. This brings the company's revenue in the last twelve months to 2.56M, down -41.70% year-over-year. In the fiscal year ending October 31, 2025, RAMM Pharma had annual revenue of 3.36M, down -22.60%.

• Revenue (ttm): 2.56M
• Revenue Growth: -41.70%
• P/S Ratio: 0.70
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	3.36M	-981.34K	-22.60%
Oct 31, 2024	4.34M	-723.29K	-14.28%
Oct 31, 2023	5.07M	1.17M	29.96%
Oct 31, 2022	3.90M	-218.63K	-5.31%
Oct 31, 2021	4.12M	-1.33M	-24.40%

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 28, 2026

Data Sources Report a data error